These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 318761)

  • 1. Tris(2,3-dibromopropyl) phosphate: mutagenicity of a widely used flame retardant.
    Prival MJ; McCoy EC; Gutter B; Rosendranz HS
    Science; 1977 Jan; 195(4273):76-8. PubMed ID: 318761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenic activation of tris(2,3-dibromopropyl)phosphate: the role of microsomal oxidative metabolism.
    Søderlund EJ; Nelson SD; Dybing E
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):112-21. PubMed ID: 40390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity of derivatives of the flame retardant tris(2,3-dibromopropyl) phosphate: halogenated propanols.
    Carr HS; Rosenkranz HS
    Mutat Res; 1978 Jul; 57(3):381-4. PubMed ID: 353552
    [No Abstract]   [Full Text] [Related]  

  • 4. Activation mechanism of tris(2,3-dibromopropyl)phosphate to the potent mutagen, 2-bromoacrolein.
    Nelson SD; Omichinski JG; Iyer L; Gordon WP; Soderlund EJ; Dybing E
    Biochem Biophys Res Commun; 1984 May; 121(1):213-9. PubMed ID: 6375666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and mutagenicity of selectively methylated analogs of tris(2,3-dibromopropyl)phosphate and 1,2-dibromo-3-chloropropane.
    Omichinski JG; Søderlund EJ; Bausano JA; Dybing E; Nelson SD
    Mutagenesis; 1987 Jul; 2(4):287-92. PubMed ID: 3325760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new mutagenic and genotoxic response of the flame retardant tris(2,3-dibromopropyl)phosphate. Activation by singlet oxygen.
    McCoy E; Hyman J; Rosenkranz HS
    Mutat Res; 1980 Mar; 77(3):209-14. PubMed ID: 6991918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative genotoxicity studies of the flame retardant tris(2,3-dibromopropyl)phosphate and possible metabolites.
    Holme JA; Søderlund EJ; Hongslo JK; Nelson SD; Dybing E
    Mutat Res; 1983 Dec; 124(3-4):213-24. PubMed ID: 6686285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Another flame retardant, tris-(1,3-dichloro-2-propyl)-phosphate, and its expected metabolites are mutagens.
    Gold MD; Blum A; Ames BN
    Science; 1978 May; 200(4343):785-7. PubMed ID: 347576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism in vitro of tris(2,3-dibromopropyl)-phosphate: oxidative debromination and bis(2,3-dibromopropyl)phosphate formation as correlates of mutagenicity and covalent protein binding.
    Søderlund EJ; Gordon WP; Nelson SD; Omichinski JG; Dybing E
    Biochem Pharmacol; 1984 Dec; 33(24):4017-23. PubMed ID: 6508849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenicity of bis- and mono-(2,3-dibromopropyl)phosphate, and their salts used as flame retardants, in the Salmonella/microsome system.
    Nakamura A; Tateno N; Iwata T; Kojima S; Kaniwa M; Kawamura T
    Mutat Res; 1983 Apr; 117(1-2):1-8. PubMed ID: 6339901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flame-retardant additives as possible cancer hazards.
    Blum A; Ames BN
    Science; 1977 Jan; 195(4273):17-23. PubMed ID: 831254
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased mutagenicity of 1,2-dibromo-3-chloropropane and tris(2,3-dibromopropyl)phosphate in Salmonella TA100 expressing human glutathione S-transferases.
    Simula TP; Glancey MJ; Söderlund EJ; Dybing E; Wolf CR
    Carcinogenesis; 1993 Nov; 14(11):2303-7. PubMed ID: 8242859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenicity of Tris(2,3-dibromopropyl) phosphate in mammalian gonad and bone marrow tissue.
    Salamone MF; Katz M
    J Natl Cancer Inst; 1981 Apr; 66(4):691-5. PubMed ID: 6939915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity studies on the mutagenicity of tris(2,3-dibromopropyl) phosphate (Tris-BP) and its metabolites in Salmonella.
    Zeiger E; Pagano DA; Nomeir AA
    Environ Mutagen; 1982; 4(3):271-7. PubMed ID: 7094911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genotoxicity and nephrotoxicity studies of the two halogenated flame retardants tris(1,3-dichloro-2-propyl)phosphate and tris(2,3-dibromopropyl)phosphate.
    Søderlund EJ; Dybing E; Holme JA; Hongslo JK; Rivedal E; Sanner T; Nelson SD
    Acta Pharmacol Toxicol (Copenh); 1985 Jan; 56(1):20-9. PubMed ID: 3883695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tris(2,3-dibromopropyl) phosphate.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1979 Oct; 20():575-88. PubMed ID: 397179
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies of possible absorption of a flame retardant from treated fabrics worn by rats and humans.
    St John LE; Eldefrawi ME; Lisk DJ
    Bull Environ Contam Toxicol; 1976 Feb; 15(2):192-7. PubMed ID: 943192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of mammalian mutagenicity of the potent bacterial mutagen tris(2,3-dibromopropyl) phosphate and its metabolite 2-bromoacrolein.
    van Beerendonk GJ; Klein JC; Tijdens RB; Lichtenauer-Kaligis EG; Tasseron-de Jong JG; Meerman JH
    Mutat Res; 1998 Jul; 415(3):201-11. PubMed ID: 9714806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of the flame retardant, tris(1,3-dichloro-2-propyl) phosphate, in the rat.
    Lynn RK; Wong K; Garvie-Gould C; Kennish JM
    Drug Metab Dispos; 1981; 9(5):434-41. PubMed ID: 6117442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism, distribution, and excretion of the flame retardant, tris(2,3-dibromopropyl) phosphate (tris-bp) in the rat: identification of mutagenic and nephrotoxic metabolites.
    Lynn RK; Garvie-Gould C; Wong K; Kennish JM
    Toxicol Appl Pharmacol; 1982 Mar; 63(1):105-19. PubMed ID: 7071866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.